Dermatology Treatment Wins 2021 Biomedical Innovation Cup! |
|
Congratulations to U-M's Lola Eniola-Adefeso, Ph.D., for winning this year's Biomedical Innovation Cup with her project Novel Dermatology Treatment for Double Chin, a bile salt-based microparticle treatment for double chin.
FFMI hosted the virtual Biomedical Innovation Cup on April 28 in conjunction with the Michigan Venture Showcase, a collaboration between the Midwest Growth Capital Symposium and InvestMidwest. The event was moderated by Denise Graves, University Relations Director, Michigan Economic Development Corporation, and the winners were chosen by a panel of investors. |
|
Commercialization Education |
|
Sign Up for May 18 Innovation Studio |
|
Looking for feedback and input on your biomedical innovation? Join the Fast Forward Medical Innovation team for Innovation Studio, virtual office hours that give life science innovators of all levels the chance to address project needs, challenges, or questions. Participants can get individual feedback on:
- innovation concepts
- opportunities for commercialization education
- funding resources
- any other innovation concerns that faculty, staff, or trainees may have
The Innovation Studio is available for 30-minute consultations via Zoom every third Tuesday of the month. The next available consultations will take place Tuesday, May 18, 2021, between 2:00pm-3:30pm. Space is limited.
|
|
Register Today! Ask the Experts: A Biomedical Innovation Forum |
|
Join Fast Forward Medical Innovation, in partnership with the U.S. Economic Development Administration, for a virtual event where our panel of experts from the life science investment community will provide insight on trends within the industry and reveal investment criteria considered when evaluating emerging technologies.
Wednesday, June 16, 2021
12:00pm-2:00pm
Following the panel discussion, a virtual poster session will provide project teams from the FFMI Hub at U-M an opportunity for constructive feedback and coaching on their business case through open discussion with investment professionals and attendees.
|
|
FFMI fastpace Kicks Off 14th Cohort |
|
The 14th cohort of the FFMI fastPACE Course is in full gear with 14 project teams (two therapeutics, eight devices/diagnostics, four health IT) from U-M, Ferris State, Wayne State, Henry Ford Health System, Michigan State, Beaumont, Western, U-M Flint, and Michigan Tech.
This groundbreaking, four-week program provides a real-world learning experience for researchers exploring the commercial viability of a biomedical technology. The course shows clinician-researchers and biomedical research scientists how to successfully put their ideas on viable paths to commercialization through a process of accelerated business planning and customer discovery.
|
|
FFMI Train-the-Trainer Program Offers Commercialization Education to Biomedical Innovators Across the Country |
|
In parallel to the FFMI fastPACE Course, FFMI is holding the Train-the-Trainer program. This session's participants include UT Southwestern, Medical College of Wisconsin, UC San Diego, University of Mississippi, Columbia University, Ohio State University, and the University of North Carolina.
Train-the-Trainer gives participating CTSA organizations the opportunity to observe our expert teaching team and learn how to launch this program at their home institutions, providing the biomedical faculty with the knowledge and tools necessary to navigate the initial process of innovation and commercialization.
|
|
FFMI Is Excited to Welcome A New Team Member! |
|
Kasia Glanowska, Ph.D., is the new Michigan Biomedical Venture Fund Analyst and joins us from U-M Tech Transfer where she worked in Technology Marketing. Before her adventure with the Tech Transfer Office, she was a neuroscientist. She holds a Ph.D. from the University of Virginia and a Masters in Biotechnology from the Jagiellonian University in Krakรณw Poland. She also has experience in market research and consulting for biomedical start-up companies.
Kasia is a life-long practitioner of traditional Ashtanga Yoga and also loves traveling, great literature, and live music.
Welcome, Kasia!
|
|
Genomenon, Inc., Honored with Prestigious Award |
|
The award recognizes companies recently financed by members of the ACA that display an inspiring level of creativity, innovativeness, and ingenuity.
|
|
RFA Open! Michigan-Pittsburgh-Wyss Regenerative Medicine Resource Center: Interdisciplinary Translational Project Program |
|
The Interdisciplinary Translational Project Program seeks to identify promising regenerative medicine/ tissue engineering technologies that address a clear, unmet, clinical need with market potential in the dental, oral, and craniofacial space, and to catalyze the clinical translation of these technologies towards FDA submissions. The long-term goal is to achieve high-impact outcomes in the clinical marketplace.
Research Areas: Regenerative medicine/tissue engineering therapies for dental, oral, and craniofacial applications
Eligibility: Applications are accepted from teams and investigators from academic/non-profit institutions as well as from for-profit entities
Amount: One-year grants of up to $300,000 per project
Deadline: Pre-proposal due on June 1, 2021
|
|
NCBI Midwest Workshops in June |
|
Monday, June 7, 9:00am-12:00pm
Tuesday, June 8, 9:00am-12:00pm
Monday, June 14, 9:00am-12pm
Tuesday, June 15, 9:00am-12pm
|
|
XLerateHealth Flint's Bootcamp Now Accepting Applications |
|
XLerateHealth has advised over 90 companies who have raised over $215 million. Through the 12-week virtual acceleration program, companies will have the opportunity to work closely with four health systems, universities, and investors. Founders will have access to experienced coaches and mentors to build their commercialization strategy, including their intersection with customers, payers, and providers.
Previous cohorts have successfully conducted pilot studies within the Flint entrepreneurial ecosystem. Check out the XLerateHealth portfolio.
Thursday, July 15 - Thursday, September 23
Applications due by May 28
|
|
To better navigate the complexities of the U-M biomedical research enterprise, visit the Research Project Lifecycle. This interactive tool provides an overview of the resources available to you, not only within the Medical School Office of Research but also across the University of Michigan.
|
|
Fast Forward Medical Innovation is part of the Office of Research, where our mission is to foster an environment of innovation and efficiency that serves the U-M Medical School community and supports biomedical science from insight to impact.
|
|
|
|
|
|
|
